Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-13T00:49:34.186Z Has data issue: false hasContentIssue false
  • English
  • Français

Nosocomial Transmission of Human Immunodeficiency Virus and Subsequent Transmission of Multidrug-Resistant Tuberculosis in a Healthcare Worker

Published online by Cambridge University Press:  02 January 2015

Renée Ridzon ,
Thomas Kenyon ,
Roberta Luskin-Hawk ,
Carol Schultz ,
Sarah Valway  and
Ida M. Onorato
Get access Rights & Permissions [Opens in a new window]

Abstract

A phlebotomist with nosocomially acquired human immunodeficiency virus infection developed tuberculosis 10 months after exposure to multidrug-resistant Mycobacterium tuberculosis during a nosocomial outbreak. Healthcare workers with immunosuppression are at increased risk of tuberculosis if infected and, if exposed, should be considered for preventive therapy regardless of tuberculin skin-test status.

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 18 , Issue 6 , June 1997 , pp. 422 - 423
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Kenyon, TA, Ridzon, R, Luskin-Hawk, R, et al. A nosocomial outbreak of multidrug-resistant tuberculosis. Ann Intern Med. In press.Google Scholar
2. Van Embden, JDA, Cave, MD, Crawford, JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406–409.CrossRefGoogle ScholarPubMed
3. Stead, WW. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis 1967;95:729–745.Google Scholar
4. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. MMWR 1994;43(RR-13):1–132.Google Scholar
5. Small, PM, Shafer, RW, Hopewell, PC, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV disease. N Engl J Med 1993;328:1137–1144.Google Scholar
6. Selwyn, PA, Hartel, D, Lewis, VA, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989;230:545–550.CrossRefGoogle Scholar
7. Daley, CL, Small, PM, Schecter, GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the immunodeficiency virus. N Engl J Med 1992;326:231–235.CrossRefGoogle ScholarPubMed
8. Centers for Disease Control. Management of persons exposed to multi-drug resistant tuberculosis. MMWR 1992;41(No. RR-11):61–71.Google Scholar
9. Centers for Disease Control and Prevention. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. MMWR 1995;44(RR-8):9–10.Google Scholar